LIVE ~ Clinical Review for Oncologists and Pharmacists - Biosimilars, 6/2/21
- Social Media Coordinator
- May 13, 2021
- 1 min read
Updated: Jun 1, 2021
Objectives:
o To consider the economic burden of biologics
o To review the clinical profile of UDENYCA®, including mechanism of action, efficacy, safety, indications, and dosing o To examine the clinical development program for UDENYCA®, including key analytical, pharmacology, immunogenicity, and safety studies
o To provide an overview of patient services through Coherus COMPLETE
Comments